PCS holds 37.7% of PBM market through three quarters of 1994 -- Walsh/PMSI data.
PCS HAS 37.7% SHARE OF PHARMACY BENEFIT MANAGEMENT MARKET based on third quarter 1994 retail prescriptions, according to Walsh America PMSI data presented by VP-Marketing & Sales Joe Combs at the National Association of Pharmaceutical Manufacturers Annual Meeting in Las Croabas, Puerto Rico Feb. 2. According to the Walsh data, PCS is the number one PBM in terms of managed retail prescriptions by a wide margin, and has a 9% share of the total retail prescription market.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth